[Treatment of duodenal ulcer with famotidine]. / Therapie des Ulcus duodeni mit Famotidin.
Wien Med Wochenschr
; 137(17): 409-11, 1987 Sep 15.
Article
en De
| MEDLINE
| ID: mdl-2891224
ABSTRACT
In a prospective double blind study the efficacy and safety of the new H2-receptor antagonist famotidine was compared with ranitidine. 48 patients with endoscopically proven duodenal ulcer were randomly allocated to receive famotidine 40 mg once at night, 20 mg bid, 40 mg bid or ranitidine 150 mg bid. After 4 weeks of treatment the ulcers of 7/12, 10/12, 9/12 and 6/12 patients were healed; the corresponding rates after 8 weeks were 9/12, 12/12, 11/12 and 10/12. Statistically there was no significant difference between the various groups. Adverse events of any clinical importance were not observed. These data indicate, that famotidine is as effective and as safe as ranitidine for the treatment of acute duodenal ulcer.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Úlcera Duodenal
/
Antagonistas de los Receptores H2 de la Histamina
/
Antiulcerosos
Tipo de estudio:
Clinical_trials
/
Observational_studies
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
De
Revista:
Wien Med Wochenschr
Asunto de la revista:
MEDICINA
Año:
1987
Tipo del documento:
Article